Yael Glassman
Yael is the VP of Business Development and Strategy for the Medtronic Diabetes. Previously, Yael was the CEO of nutrition science startup, Nutrino Health where she led the company to a successful acquisition by Medtronic in December of 2018. Before Nutrino, Yael held multiple commercial roles in healthcare technology companies, including VP of Business Development at Sensible Medical, VP Marketing and Strategy at telemedicine leader, AmWell and Director care management marketing at TriZetto (acquired by Cognizant). Yael also serves on the board of directors of Grin, a tele-dentistry company and she is an angel investor in startup companies. Yael holds a BA in Psychology from Hebrew University and an MBA from MIT Sloan of Management.